Vaginal leucocyte counts in women with bacterial vaginosis: relation to vaginal and cervical infections.

Department of Medicine, University of Alabama at Birmingham, 35294-0007, USA.
Sexually Transmitted Infections (Impact Factor: 3.08). 11/2004; 80(5):401-5. DOI: 10.1136/sti.2003.009134
Source: PubMed

ABSTRACT To evaluate whether an elevated vaginal leucocyte count in women with bacterial vaginosis (BV) predicts the presence of vaginal or cervical infections, and to assess the relation of vaginal WBC counts to clinical manifestations.
We retrospectively analysed the relation of vaginal leucocyte counts to vaginal and cervical infections and to clinical manifestations in non-pregnant women diagnosed with BV at an STD clinic visit.
Of 296 women with BV studied, the median age was 24 years and 81% were African-American. Elevated vaginal leucocyte counts were associated with objective signs of vaginitis and cervicitis and also predicted candidiasis (OR 7.9, 95% CI 2.2 to 28.9), chlamydia (OR 3.1, 95% CI 1.4 to 6.7), gonorrhoea (OR 2.7, 95% CI 1.3 to 5.4), or trichomoniasis (OR 3.4, 95% CI 1.6 to 7.3). In general, as a screening test for vaginal or cervical infections, vaginal leucocyte count had moderate sensitivities and specificities, low positive predictive values, and high negative predictive values.
An elevated vaginal leucocyte count in women with BV was a strong predictor of vaginal or cervical infections. Vaginal leucocyte quantification may provide an alternative approach to assessing need for empirical therapy for chlamydia and gonorrhoea, particularly in resource-limited high STD risk settings that provide syndromic management.

  • [Show abstract] [Hide abstract]
    ABSTRACT: STUDY OBJECTIVE: Mycoplasma genitalium (MG) is a sexually transmitted pathogen linked to female morbidity, but testing for MG is not standardized. We aimed to determine which point-of-care (POC) vaginal tests could predict MG infection. DESIGN, SETTING, PARTICIPANTS: A cross sectional study recruited sexually active adolescent women, aged 14-22 y (n = 217) from an urban medical center. INTERVENTIONS AND MAIN OUTCOME MEASURES: Vaginal swabs were POC tested for pH, amines, clue cells, sialidase, and Trichomonas vaginalis (TV). MG was detected by research-use-only transcription mediated amplification (TMA) assay. Presence of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) were confirmed using TMA. Three criteria were required for diagnosis of clinical BV: pH > 4.5, presence of amines, and >20% clue cells. Associations were assessed using logistic regression (LR). RESULTS: TMA detected MG in 30 (14%), CT in 49 (23%), and NG in 21 (10%) of the samples tested. POC vaginal tests were positive for TV in 21%, amines in 52%, clue cells in 33%, sialidase in 22%, pH > 4.5 in 56%, and clinical BV in 19% of the samples tested. Using LR, pH > 4.5 was a predictor of MG (odds ratio 4.4, P < .05). Of 131 women without clinical BV or TV, 25% of those with pH > 4.5 had MG, compared to 9% of those with pH ≤ 4.5 (P = .02). CONCLUSIONS: Until standardized, approved testing for MG is available, pH may be a useful indicator to suspect MG, especially in the absence of BV and TV.
    Journal of pediatric and adolescent gynecology 11/2012; 26(1). DOI:10.1016/j.jpag.2012.09.005 · 0.90 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background. The secretory leukocyte protease inhibitor (SLPI) is responsible for regulating inflammatory damage and innate and adaptive immune responses of the vaginal mucosa. Depressed cervicovaginal SLPI levels have been correlated with both Trichomonas vaginalis (TV) and poor reproductive health outcomes.Methods. We measured levels of SLPI in 215 vaginal specimens collected from adolescent women ages 14-22. Log-transformed SLPI values were compared by ANOVA or by unpaired t test before and after adjusting for confounding effects through the propensity score method.Results. Women on hormonal contraceptives and those with abnormal vaginal pH had lower SLPI levels as compared to their peers. After propensity score adjustment for race, behavioral factors, hormonal use and other STIs, SLPI levels were lower in women with positive TV antigen test, pH>4.5, vaginal leukocytosis, recurrent compared to initial TV infection, and were lowest in those with highest TV load.Conclusions. SLPI was reduced by >50% in a TV load dependent manner. Future research should consider whether identifying and treating women with low levels of TV infection (before they become wet mount positive) would prevent the loss of SLPI and impaired vaginal immunity. SLPI could be used as a vaginal health marker to evaluate interventions and vaginal products.
    The Journal of Infectious Diseases 01/2013; DOI:10.1093/infdis/jit039 · 5.85 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: El objetivo del trabajo fue validar el alto valor predictivo de BACOVA (Balance del contenido vaginal, disponible en en el diagnóstico microscópico diferencial de vaginosis bacteriana (VB) y vaginitis microbiana inespecífica (VMI). Fueron estudiadas 299 embarazadas sintomáticas. Se determinó por microscopía el Valor Numérico (Nugent) (VN), células guía (CG), morfotipos extraños (Mex), leucocitos por campo (Lpc), tricomonas (TV) y levaduras (LE) con lectura a 400X. Los resultados globales fueron: VN de 7 a 10, 16,4% del total de casos. BACOVA permitió diferenciar 11,7% de los casos con VN de 7 a 10, con reacción inflamatoria vaginal (RIV) menor de 10 Lpc, como casos típicos de BV. Con igual VN se detectó 4,7% de casos con RIV con más de 10 Lpc, compatibles con VMI. En sólo 7,3% de los casos de LE detectadas por microscopía (20,4% en total), se confirmó una RIV significativa. Hubo 2,7% del total de casos con RIV significativa, pH<4,5 y resultado negativo para el resto de los criterios estudiados. La determinación de la RIV, fue imprescindible, junto al VN, en el diagnóstico diferencial de VB y VMI. La RIV también es necesaria para establecer la significación clínica de la presencia de levaduras. BACOVA detecta casos con RIV significativa (2,7%), como único marcador, con pH inferior a 4,5, compatibles con infección del tracto genital superior.
    Acta bioquímica clínica latinoamericana 06/2007; 41(2). · 0.09 Impact Factor


1 Download
Available from